Pharmaceutical Statistics has a new Editor-in-chief

Jan 02, 2018

ImageWe are pleased to welcome John Scott to the Editorial team of Pharmaceutical Statistics. John joins David Morgan and Jorgen Seldrup as one of three Editors-in-Chief working on the journal.

John Scott supervises the statisticians at the FDA's Center for Biologics Evaluation and Research, who review applications for vaccines, blood products, and advanced therapeutic products such as cellular and gene therapies. Before joining the FDA in 2008, he worked in psychiatric clinical trials at the University of Pittsburgh Medical Center and did neuroimaging research with the Neurostatistics Laboratory at McClean Hospital.

John holds a Ph.D. in Biostatistics from the University of Pittsburgh and an M.A. in Mathematics from Washington University in St. Louis. His research interests include Bayesian and adaptive clinical trial design and analysis, drug and vaccine safety, data and text mining, and benefit-risk assessment.